Abstract
In March 2020 the SARS-CoV-2infection (COVID-19) was declared a pandemic. In response to its world-wide outbreak radical measures were taken by governments across the world including curfew, quarantine, travel bans, social distancing, work place and school closures, etc, to reduce the transmission of the virus. These measures led to dramatic social and economic changes for the general population, in addition to the fears and worries related to the disease and its contraction. First studies report the impact of the pandemic on mental well-being of the general population showing increased levels of anxiety, stress and depression. In this study, we compare the impact of the pandemic on two European countries – the UK and Germany, which reported their first cases within a week. 241 residents of the UK and 541 residents of Germany filled in an online survey, including questions on COVID-19 exposure, impact on financial situation and work, substance and media consumption, self-reported mental and physical health, as well as including two clinical questionnaires, the general mental health Symptom Check List-27 (SCL-27) and the Schizotypal Personality Questionnaire. Data collection was completed between 27/04/20-31/05/20. We found distinct differences between the two countries. UK responders reported a stronger direct impact on their health, financial situation and their families. UK responders had higher clinical scores on the SCL-27, with a higher percentage being above cut-off. Interestingly, however, we found that German responders were less hopeful for an end of the pandemic and more concerned about their life-stability. Generally, we found that a younger age, being female, lower education, poorer mental and physical health before the pandemic, as well as more social media and substance consumption was associated with a higher clinical risk. As 25% of all responders report a subjective worsening of the general psychological symptoms and 20-50% of responders reaching the clinical cut-off for depressive, dysthymic and anxieties, future pandemics require a tailored intervention system to assist not only people vulnerable for mental health problems, but also large proportions of the general public.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
FK received funding from the European Union's Horizon 2020 [Grant number 754462].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Ethical Commission Board of the Technical University Munich (250/20 S).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used in this paper is available on personal request.